Circulating tumor cells and FDG-PET/CT: biological and functional methods for therapeutic monitoring in metastatic breast

被引：0
|
作者：
Cristofanilli, M.
De Giorgi, U.
Rohren, E.
Ueno, N. T.
Miller, C.
Doyle, G., V
Jackson, S.
Andreopoulou, E.
Handy, B. C.
Hortobagyi, G. N.
Macapinlac, H. A.
Fritsche, H. A.
Valero, V.
机构：
[1] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Immunicon Corp, Huntingdon Valley, PA USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：362S / 362S
页数：1
相关论文
共 50 条
  • [21] Interrater agreement when using PERCIST criteria for FDG-PET/CT response monitoring of metastatic breast cancer
    Holm, J.
    Vilstrup, M.
    Bulow, J.
    Ljungstrom, L.
    Oltmann, H.
    Alamdari, T.
    Vogsen, M.
    Gerke, O.
    Hoilund-Carlsen, P.
    Hildebrandt, M. G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S215 - S215
  • [22] FDG-PET in monitoring therapy of breast cancer
    H.-J. Biersack
    H. Bender
    H. Palmedo
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : S112 - S117
  • [23] Assessing and monitoring therapeutic response of breast cancer and cervical cancer with FDG-PET
    Dehdashti, F.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 : 30 - 30
  • [24] FDG-PET in monitoring therapy of breast cancer
    Biersack, HJ
    Bender, H
    Palmedo, H
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (Suppl 1) : S112 - S117
  • [25] Clinical application of FDG-PET/CT in metastatic infections
    Kouijzer, Ilse J.
    Vos, Fidel J.
    Bleker-Rovers, Chantal P.
    Oyen, Wim J.
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 61 (02): : 232 - 246
  • [26] Breast cancer: treatment response assessment with FDG-PET/CT in the neoadjuvant and in the metastatic setting
    Groheux, David
    Ulaner, Gary A.
    Hindie, Elif
    [J]. CLINICAL AND TRANSLATIONAL IMAGING, 2023, 11 (05) : 439 - 452
  • [27] Role of FDG-PET/CT in Metastatic Staging of Newly Diagnosed Primary Breast Cancer
    Niikura, N.
    Costelloe, C.
    Madewell, J. E.
    Hayashi, N.
    Yu, T-K
    Liu, J.
    Palla, S. L.
    Tokuda, Y.
    Theriault, R. L.
    Hortobagyi, G. N.
    Ueno, N. T.
    [J]. CANCER RESEARCH, 2010, 70
  • [28] Assessment of hormonal therapy response using FDG-PET/CT in metastatic breast cancer
    Mortazavi-Jehanno, N.
    Giraudet, A. L.
    Edeline, V.
    Banayan, S.
    Madar, O.
    Tubiana, M.
    Pecking, A. P.
    Alberini, J. L.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S176 - S176
  • [29] Breast cancer: treatment response assessment with FDG-PET/CT in the neoadjuvant and in the metastatic setting
    David Groheux
    Gary A. Ulaner
    Elif Hindie
    [J]. Clinical and Translational Imaging, 2023, 11 : 439 - 452
  • [30] Early response monitoring with FDG-PET in a phase I study in metastatic breast cancer
    Homans, F
    Stroobants, S
    Dupont, P
    Vergote, I
    Mortelmans, L
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1166 - 1166
12345